ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
AstraZeneca plans to cut 8,000 jobs across the firm by 2014. The new cuts, about 12% of the workforce, come on top of 15,000 job cuts previously announced, 12,600 of which were already eliminated over the past two years. Within R&D, the firm plans to cut as many as 3,500 positions to realize annual savings of $1 billion. AstraZeneca also said it would restructure R&D by reducing the number of disease-area targets, expanding contract research, and consolidating research sites.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X